probenecid has been researched along with Shock, Septic in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falsini, S | 1 |
| Cellai, MP | 1 |
| Angiolini, P | 1 |
| Cavuta, M | 1 |
| Novelli, GP | 1 |
1 other study available for probenecid and Shock, Septic
| Article | Year |
|---|---|
[Reduced glutathione and L-cysteine in endotoxic shock in the rat].
Topics: Animals; Cysteine; Endotoxins; Ethanol; Glutathione; Lipopolysaccharides; Male; Oxidation-Reduction; | 1994 |